• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.用于研究抗生素浓度和消除速率对抗菌活性影响的新型体外模型。
Antimicrob Agents Chemother. 1978 Apr;13(4):570-6. doi: 10.1128/AAC.13.4.570.
2
[Correlation between antibacterial activity of some cephalosporins and pharmacokinetic properties "in vitro" (author's transl)].
Quad Sclavo Diagn. 1979 Jun;15 Suppl 1:785-92.
3
[An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].
Infection. 1977;5(4):236-41. doi: 10.1007/BF01640788.
4
[Timed bacteriostatic and bactericidal activities of cefmetazole against selected gram-negative bacteria].
Jpn J Antibiot. 1982 Sep;35(9):2288-92.
5
Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae.头孢唑林、头孢西丁和头孢美唑对大肠杆菌和肺炎克雷伯菌的杀菌活性。
Chemotherapy. 1982;28(1):18-25. doi: 10.1159/000238056.
6
New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.用于评估抗生素杀菌效果的新型体外动力学模型。
Antimicrob Agents Chemother. 1980 Sep;18(3):377-81. doi: 10.1128/AAC.18.3.377.
7
Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.头孢菌素与妥布霉素联合使用对大肠杆菌、克雷伯菌和金黄色葡萄球菌临床分离株的杀菌作用。
Arzneimittelforschung. 1986 Sep;36(9):1301-2.
8
In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.新型头孢菌素抗生素头孢孟多在患者中的体外活性及药代动力学
Antimicrob Agents Chemother. 1975 Dec;8(6):679-83. doi: 10.1128/AAC.8.6.679.
9
Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.头孢菌素类抗生素的抗菌活性评估:头孢唑林、头孢噻啶、头孢噻吩和头孢氨苄。
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi. 1975 Mar;8(1):1-11.
10
Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity.
J Antibiot (Tokyo). 1970 Mar;23(3):137-48. doi: 10.7164/antibiotics.23.137.

引用本文的文献

1
Adaptation of an one-compartment pharmacodynamic chemostat for testing efficacy of ceftazidime against outside a BSL3 facility.一种单室药效学恒化器的改造,用于在生物安全三级(BSL3)设施外测试头孢他啶的疗效。
MethodsX. 2025 Jan 10;14:103167. doi: 10.1016/j.mex.2025.103167. eCollection 2025 Jun.
2
Dynamic PK/PD Infection Models for the Development and Optimisation of Antimicrobial Regimens: A Narrative Review.用于抗菌治疗方案开发与优化的动态药代动力学/药效学感染模型:叙述性综述
Antibiotics (Basel). 2024 Dec 10;13(12):1201. doi: 10.3390/antibiotics13121201.
3
Applications of the hollow-fibre infection model (HFIM) in viral infection studies.中空纤维感染模型(HFIM)在病毒感染研究中的应用。
J Antimicrob Chemother. 2022 Dec 23;78(1):8-20. doi: 10.1093/jac/dkac394.
4
The Application of Hollow Fiber Cartridge in Biomedicine.中空纤维柱在生物医学中的应用。
Pharmaceutics. 2022 Jul 18;14(7):1485. doi: 10.3390/pharmaceutics14071485.
5
A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models.一种能够在体外复制药代动力学(PK)特征的微流控系统可提高临床前模型中体内疗效预测的准确性。
PLoS Biol. 2022 May 26;20(5):e3001624. doi: 10.1371/journal.pbio.3001624. eCollection 2022 May.
6
Antibacterial pathway of cefquinome against Staphylococcus aureus based on label-free quantitative proteomics analysis.基于无标记定量蛋白质组学分析的头孢喹肟对金黄色葡萄球菌的抗菌途径。
J Microbiol. 2021 Dec;59(12):1112-1124. doi: 10.1007/s12275-021-1201-x. Epub 2021 Nov 9.
7
Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the β-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282.β-内酰胺酶抑制剂ETX1317及其口服可用前药ETX0282的药代动力学/药效学测定及临床前药代动力学
ACS Infect Dis. 2020 Jun 12;6(6):1378-1388. doi: 10.1021/acsinfecdis.0c00019. Epub 2020 May 14.
8
Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an Pharmacodynamic Model.头孢洛扎-他唑巴坦与黏菌素联合用药在药效学模型中对包括高风险克隆在内的广泛耐药铜绿假单胞菌的疗效
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02542-19.
9
Generating Robust and Informative Nonclinical and Bacterial Infection Model Efficacy Data To Support Translation to Humans.生成稳健且信息丰富的非临床和细菌感染模型药效数据,以支持向人体的转化。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02307-18. Print 2019 May.
10
Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.四十年来囊性纤维化患者β-内酰胺类抗生素的药代动力学研究
Clin Pharmacokinet. 2019 Feb;58(2):143-156. doi: 10.1007/s40262-018-0678-x.

本文引用的文献

1
A simple dilution analog computer for simulation of drug distribution processes.一种用于模拟药物分布过程的简易稀释模拟计算机。
J Pharm Sci. 1969 Nov;58(11):1375-8. doi: 10.1002/jps.2600581117.
2
Trimodal response of Escherichia coli and Proteus mirabilis to penicillins.大肠杆菌和奇异变形杆菌对青霉素的三联反应。
Nature. 1970 Oct 31;228(5270):457-8. doi: 10.1038/228457a0.
3
7-(Alpha-(1-methyl-4-pyridinothio)-acetamido) cephalosporanic acid.7 -(α-(1-甲基-4-吡啶硫基)-乙酰胺基)头孢烷酸
Antimicrob Agents Chemother. 1972 Jan;1(1):67-72. doi: 10.1128/AAC.1.1.67.
4
[Celospor (C 36278-Ba), a new antibiotic of the cephalosporin series: pharmacokinetics and clinical trial].
Schweiz Med Wochenschr. 1973 May 12;103(19):718-24.
5
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients.“广谱”青霉素、头孢菌素及其他抗生素对从菌血症患者中分离出的革兰氏阴性杆菌的抗菌作用。
Ann N Y Acad Sci. 1967 Sep 27;145(2):224-36. doi: 10.1111/j.1749-6632.1967.tb50221.x.
6
Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.头孢唑林和头孢噻吩在人体静脉注射和肌肉注射后血药浓度及尿排泄数据的药代动力学解释
Antimicrob Agents Chemother. 1975 May;7(5):606-13. doi: 10.1128/AAC.7.5.606.

用于研究抗生素浓度和消除速率对抗菌活性影响的新型体外模型。

New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.

作者信息

Grasso S, Meinardi G, de Carneri I, Tamassia V

出版信息

Antimicrob Agents Chemother. 1978 Apr;13(4):570-6. doi: 10.1128/AAC.13.4.570.

DOI:10.1128/AAC.13.4.570
PMID:352258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC352290/
Abstract

A new apparatus is described which serves to investigate the in vitro antibacterial activity of antibiotics as a function of different concentration time curves. The apparatus can be adjusted to simulate the biexponential serum level curves observed in vivo after oral or intramuscular administration. Preliminary studies were carried out with a cephalosporin derivative, cefazolin, against Escherichia coli and Klebsiella sp. strains simulating initial concentrations of 5, 10, and 20 mug/ml that decreased exponentially with half-lives of 30, 60, and 120 min. Surviving cells were counted at 1-h intervals for 10 h. In all the situations tested there was an initial phase of rapid bactericidal activity followed by a phase of bacteriostatic activity, whose length depended on the drug elimination rate but was relatively independent of the initial concentrations. Bacterial regrowth occurred when the antibiotic concentration fell below the minimum inhibitory concentration of the drug against the strains tested. The antibacterial activity of cefazolin, cephacetrile, and cephradine against E. coli and Klebsiella strains was also investigated, in a medium containing 4% human albumin, simulating the serum level curves observed in humans after an intramuscular dose of 1 g. The results obtained suggest that, for cephalosporins, a longer half-life might be more useful than higher peak levels.

摘要

本文描述了一种新装置,该装置用于研究抗生素的体外抗菌活性与不同浓度-时间曲线的关系。该装置可进行调节,以模拟口服或肌肉注射后在体内观察到的双指数血清水平曲线。使用头孢菌素衍生物头孢唑林对大肠杆菌和克雷伯菌属菌株进行了初步研究,模拟初始浓度为5、10和20μg/ml,其浓度以30、60和120分钟的半衰期呈指数下降。在10小时内每隔1小时对存活细胞进行计数。在所有测试情况下,均存在一个快速杀菌活性的初始阶段,随后是一个抑菌活性阶段,其持续时间取决于药物消除率,但相对独立于初始浓度。当抗生素浓度降至低于该药物对测试菌株的最低抑菌浓度时,细菌会重新生长。还在含有4%人白蛋白的培养基中研究了头孢唑林、头孢乙腈和头孢拉定对大肠杆菌和克雷伯菌菌株的抗菌活性,模拟了1g肌肉注射剂量后在人体中观察到的血清水平曲线。所得结果表明,对于头孢菌素类药物,较长的半衰期可能比较高的峰值水平更有用。